Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1020)
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
12,610
Price
$64.42
Total Value
$812.34K
Shares Held After
798,335
% of Holdings
1.6%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
68,265
Price
$63.83
Total Value
$4.36M
Shares Held After
810,945
% of Holdings
7.8%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
19,125
Price
$62.62
Total Value
$1.20M
Shares Held After
879,210
% of Holdings
2.1%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
88,487
Price
$64.28
Total Value
$5.69M
Shares Held After
716,311
% of Holdings
11.0%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
11,513
Price
$63.13
Total Value
$726.82K
Shares Held After
804,798
% of Holdings
1.4%
Keros Therapeutics, Inc. (KROS)
Farzan Nima — Director
Shares
2,625
Price
$10.73
Total Value
$28.17K
Shares Held After
9,767
% of Holdings
21.2%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
3,471
Price
$50.00
Total Value
$173.55K
Shares Held After
67,468
% of Holdings
4.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
1,420
Price
$66.08
Total Value
$93.83K
Shares Held After
1,787,306
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
35,208
Price
$65.58
Total Value
$2.31M
Shares Held After
1,788,726
% of Holdings
1.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
46,108
Price
$64.47
Total Value
$2.97M
Shares Held After
1,823,934
% of Holdings
2.5%
Keros Therapeutics, Inc. (KROS)
Knowles Julius — Director
Shares
2,625
Price
$10.73
Total Value
$28.17K
Shares Held After
10,958
% of Holdings
19.3%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
19,575
Price
$6.13
Total Value
$119.99K
Shares Held After
700,000
% of Holdings
2.7%
INCYTE CORP (INCY)
Tray Thomas — Principal Accounting Officer
Shares
2,639
Price
$100.00
Total Value
$263.90K
Shares Held After
21,132
% of Holdings
11.1%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
2,670
Price
$30.87
Total Value
$82.43K
Shares Held After
46,275
% of Holdings
5.5%
Keros Therapeutics, Inc. (KROS)
Seth Alpna — Director
Shares
2,625
Price
$10.72
Total Value
$28.14K
Shares Held After
9,767
% of Holdings
21.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
40
Price
$312.23
Total Value
$12.49K
Shares Held After
1,450,253
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
964
Price
$311.36
Total Value
$300.15K
Shares Held After
1,450,293
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,652
Price
$310.43
Total Value
$823.26K
Shares Held After
1,451,257
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,784
Price
$309.49
Total Value
$861.62K
Shares Held After
1,453,909
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
4,830
Price
$308.47
Total Value
$1.49M
Shares Held After
1,456,693
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
11,461
Price
$307.68
Total Value
$3.53M
Shares Held After
1,461,523
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
589
Price
$306.33
Total Value
$180.43K
Shares Held After
1,472,984
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
544
Price
$304.81
Total Value
$165.82K
Shares Held After
1,473,573
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
176
Price
$303.17
Total Value
$53.36K
Shares Held After
1,474,117
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
640
Price
$302.24
Total Value
$193.43K
Shares Held After
1,474,293
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,474,933
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
240
Price
$311.65
Total Value
$74.80K
Shares Held After
1,378,155
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,039
Price
$310.94
Total Value
$634.00K
Shares Held After
1,378,395
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,801
Price
$309.95
Total Value
$868.16K
Shares Held After
1,380,434
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,803
Price
$308.89
Total Value
$1.17M
Shares Held After
1,383,235
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
12,729
Price
$307.81
Total Value
$3.92M
Shares Held After
1,387,038
% of Holdings
0.9%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,348
Price
$307.09
Total Value
$413.96K
Shares Held After
1,399,767
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
480
Price
$305.87
Total Value
$146.82K
Shares Held After
1,401,115
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
400
Price
$304.89
Total Value
$121.96K
Shares Held After
1,401,595
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
247
Price
$303.17
Total Value
$74.88K
Shares Held After
1,401,995
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
593
Price
$302.25
Total Value
$179.23K
Shares Held After
1,402,242
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,402,835
% of Holdings
0.0%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
1,000
Price
$12.80
Total Value
$12.80K
Shares Held After
21,969
% of Holdings
4.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$12.68
Total Value
$6.34K
Shares Held After
22,969
% of Holdings
2.1%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$54.50
Total Value
$54.50K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$550.48
Total Value
$66.06K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,298
Price
$549.06
Total Value
$712.68K
Shares Held After
18,996
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,749
Price
$548.04
Total Value
$1.51M
Shares Held After
20,294
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,033
Price
$547.00
Total Value
$565.05K
Shares Held After
23,043
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,129
Price
$545.89
Total Value
$616.31K
Shares Held After
24,076
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,545
Price
$544.94
Total Value
$841.94K
Shares Held After
25,205
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,086
Price
$544.11
Total Value
$590.91K
Shares Held After
26,750
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$542.78
Total Value
$238.82K
Shares Held After
27,836
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$541.14
Total Value
$259.75K
Shares Held After
28,276
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$539.64
Total Value
$64.76K
Shares Held After
28,756
% of Holdings
0.4%
Showing 251–300 of 1020 transactions (page 6 of 21)